Laminitis prevention and treatment through camelid serum

摘要

The present invention provides evidence that metalloprotease and other protease type enzyme peptide inhibitors present or generated by vaccination in camelid serum /plasma can be used alone or combined with other agents to prevent or treat Laminitis. The serum/ plasma and isolated or synthesised peptides listed in this patent have use in the prevention and treatment of Laminitis. In equine treatment this camel plasma and peptides outlined in this patent can be utilised to inhibit all the inflammatory protease enzymes that have been identified as the causative agents for equine laminitis.